Minh-Ha Tran, DO
- Anticoagulants
- Blood Banks
- Blood Component Removal
- Blood Transfusion
- Citrates
- Clinical Protocols
- Factor Xa
- Graft vs Host Disease
- Prothrombin
- Purpura, Thrombocytopenic, Idiopathic
- Purpura, Thrombotic Thrombocytopenic
- Recombinant Proteins
- Single-Domain Antibodies
- Transplantation Conditioning
- Trauma Centers
- Caplacizumab as rescue therapy in refractory TTP involving neurologic features. Transfus Apher Sci. 2023 Jun; 62(3):103656. Tran MH, Lee LX, Cao Y, Vu L, Pakbaz Z. PMID: 36863912.
- Diversion of prime to ameliorate citrate toxicity in pediatric extracorporeal apheresis. Transfus Apher Sci. 2020 10; 59(5):102841. Tran MH, Brown D, Woo JS, Perez-Alvarez I, Chavan R. PMID: 32546378.
- Direct oral anticoagulant (DOAC) reversal: Andexxa versus 4 factor prothrombin concentrates. Transfus Apher Sci. 2020 Apr; 59(2):102649. Tran MH, Knight B, Duong AH. PMID: 31606337.
- Massive Transfusion Protocol: ?Communication Ordering Practice Survey (MTP COPS). Am J Clin Pathol. 2016 Sep; 146(3):319-23. Tran MH, Vossoughi S, Harm S, Dunbar N, Fung M. PMID: 27510718.